During the past decade, UPMC Hillman Cancer Center - Passavant - Cranberry conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "UPMC Hillman Cancer Center - Passavant - Cranberry" #1 collaborator was "National Cancer Institute (NCI)" with 3 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "UPMC Hillman Cancer Center - Passavant - Cranberry" are "Thyroid Gland Carcinoma" (2 trials), "ALK Gene Rearrangement" (1 trials), "ALK Gene Translocation" (1 trials), "ALK Positive" (1 trials) and "Acinar Cell Carcinoma" (1 trials). Many other conditions were trialed in "UPMC Hillman Cancer Center - Passavant - Cranberry" in a lesser frequency.

Most popular intervention types in "UPMC Hillman Cancer Center - Passavant - Cranberry" are "Biological" (6 trials), "Drug" (6 trials), "Procedure" (5 trials), "Other" (3 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Computed Tomography" (3 trials), "Crizotinib" (3 trials), "Docetaxel" (3 trials), "Nivolumab" (3 trials) and "Biospecimen Collection" (2 trials). Other intervention names were less common.

The vast majority of trials in "UPMC Hillman Cancer Center - Passavant - Cranberry" are 7 trials for "All" genders.

Currently, there are NaN active trials in "UPMC Hillman Cancer Center - Passavant - Cranberry". undefined are not yet recruiting, 5 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in UPMC Hillman Cancer Center - Passavant - Cranberry, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in UPMC Hillman Cancer Center - Passavant - Cranberry, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".